financetom
Business
financetom
/
Business
/
QuinStreet Q4 revenue beats analyst estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
QuinStreet Q4 revenue beats analyst estimates
Aug 7, 2025 2:29 PM

Overview

* QuinStreet FYQ4 revenue up 32% YoY, beating analyst expectations, per LSEG data

* Adjusted EBITDA for FYQ4 meets analyst estimates, up 101% YoY

* FY25 revenue grows 78% to $1.1 bln, net income turns positive

Outlook

* QuinStreet ( QNST ) expects FYQ1 revenue of about $280 mln

* Company anticipates FYQ1 adjusted EBITDA of about $20 mln

* QuinStreet ( QNST ) sees FY26 revenue growing about 10%

* Company expects FY26 adjusted EBITDA to grow about 20%

Result Drivers

* AUTO INSURANCE DEMAND - Renewed demand from Auto Insurance clients was key to fiscal 2025 success despite moderated carrier spending growth

* HOME SERVICES GROWTH - Home Services revenue increased by 21% YoY, contributing to overall revenue growth

* INVESTMENT INITIATIVES - Ongoing investments in market and product initiatives expected to fuel future growth and margin expansion, per CEO Doug Valenti

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q4 Beat $262.05 $255.10

Revenue mln mln (6

Analysts

)

Q4 Net $3.21

Income mln

Q4 Meet $22.10 $22.10

Adjusted mln mln (6

EBITDA Analysts

)

Q4 Gross $27.85

Profit mln

Q4 $3.88

Operatin mln

g Income

Q4 $3.75

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the online services peer group is "buy"

* Wall Street's median 12-month price target for QuinStreet Inc ( QNST ) is $25.00, about 32.5% above its August 6 closing price of $16.88

* The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 16 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Volkswagen passenger cars brand struggles to hit cost-cutting goal, says Handelsblatt
Volkswagen passenger cars brand struggles to hit cost-cutting goal, says Handelsblatt
Aug 29, 2024
BERLIN (Reuters) - Volkswagen's passenger cars brand is struggling to meet its 10 billion euro ($11.14 billion) cost-cutting target, undermined by issues including low sales and missing parts, German business paper Handelsblatt reported on Wednesday. A Volkswagen spokesperson declined to comment. The brand was 2-3 billion euros short of its savings goal for this year, two sources who declined to...
Adma Biologics Insider Sold Shares Worth $1,095,600, According to a Recent SEC Filing
Adma Biologics Insider Sold Shares Worth $1,095,600, According to a Recent SEC Filing
Aug 29, 2024
03:28 AM EDT, 08/28/2024 (MT Newswires) -- Young Kwon, Director, on August 23, 2024, sold 60,000 shares in Adma Biologics ( ADMA ) for $1,095,600. Following the Form 4 filing with the SEC, Kwon has control over a total of 241,441 shares of the company, with 241,441 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1368514/000114036124038770/xslF345X05/form4.xml Price: 17.47, Change: +0.12, Percent Change: +0.69...
Adma Biologics Insider Sold Shares Worth $10,923,987, According to a Recent SEC Filing
Adma Biologics Insider Sold Shares Worth $10,923,987, According to a Recent SEC Filing
Aug 29, 2024
03:27 AM EDT, 08/28/2024 (MT Newswires) -- Adam S Grossman, Director, President and Chief Executive Officer, on August 26, 2024, sold 626,245 shares in Adma Biologics ( ADMA ) for $10,923,987. Following the Form 4 filing with the SEC, Grossman has control over a total of 3,784,109 shares of the company, with 2,059,726 shares held directly and 1,724,383 controlled indirectly....
Compass Insider Sold Shares Worth $4,329,483, According to a Recent SEC Filing
Compass Insider Sold Shares Worth $4,329,483, According to a Recent SEC Filing
Aug 29, 2024
03:29 AM EDT, 08/28/2024 (MT Newswires) -- Robert L. Reffkin, Director, Chairman and Chief Executive Officer, on August 23, 2024, sold 870,000 shares in Compass (COMP) for $4,329,483. Following the Form 4 filing with the SEC, Reffkin has control over a total of 8,772,418 shares of the company, with 944,302 shares held directly and 7,828,116 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1563190/000156319024000150/xslF345X05/wk-form4_1724806849.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved